.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Citi
Dow
US Department of Justice
Merck
Medtronic
Teva
US Army
Daiichi Sankyo
Fish and Richardson

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021067

« Back to Dashboard
NDA 021067 describes ASMANEX TWISTHALER, which is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug. Additional details are available on the ASMANEX TWISTHALER profile page.

The generic ingredient in ASMANEX TWISTHALER is mometasone furoate. There are twenty-nine drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.

Summary for NDA: 021067

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:3
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 021067

Suppliers and Packaging for NDA: 021067

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ASMANEX TWISTHALER
mometasone furoate
POWDER;INHALATION 021067 NDA Merck Sharp & Dohme Corp. 0085-1341 0085-1341-01 1 POUCH in 1 CARTON (0085-1341-01) > 1 INHALER in 1 POUCH > 120 INHALANT in 1 INHALER
ASMANEX TWISTHALER
mometasone furoate
POWDER;INHALATION 021067 NDA Merck Sharp & Dohme Corp. 0085-1341 0085-1341-02 1 POUCH in 1 CARTON (0085-1341-02) > 1 INHALER in 1 POUCH > 60 INHALANT in 1 INHALER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;INHALATIONStrength0.22MG/INH
Approval Date:Mar 30, 2005TE:RLD:Yes
Patent:► SubscribePatent Expiration:Aug 20, 2017Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Sep 17, 2018Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Sep 17, 2018Product Flag?Substance Flag?Delist Request?Y

Expired Orange Book Patents for NDA: 021067



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
Baxter
US Army
Fish and Richardson
Medtronic
Cerilliant
Julphar
Healthtrust
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot